back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-02-06 18:17 Tx date 2024-01-30 |
$MYND
MYND Life Sciences Inc. |
Bakke, Laurie
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-02-06 18:17 Tx date 2024-01-30 |
$MYND
MYND Life Sciences Inc. |
Bakke, Laurie
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-08-04 17:36 Tx date 2023-08-03 |
$MYND
MYND Life Sciences Inc. |
Tam, Lih Ming
5 - Senior Officer of Issuer
Holder: Greenlight Innovation Partners Inc. (Indirect Ownership)
|
Options
50 - Grant of options
|
$25,000
+500,000 vol $0.05 each |
500,000 | |
| Filed 2023-08-04 17:34 Tx date 2022-03-01 |
$MYND
MYND Life Sciences Inc. |
Tam, Lih Ming
5 - Senior Officer of Issuer
Holder: Greenlight Innovation Partners Inc. (Indirect Ownership)
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-08-10 15:58 Tx date 2022-08-09 |
$MYND
MYND Life Sciences Inc. |
Ritchie-Derrien, Roslyn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$6,000
+50,000 vol $0.12 each |
200,000 | |
| Filed 2022-08-10 13:26 Tx date 2022-08-09 |
$MYND
MYND Life Sciences Inc. |
Nicoll, Scott
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$18,000
+150,000 vol $0.12 each |
150,000 | |
| Filed 2022-08-10 13:26 Tx date 2022-08-09 |
$MYND
MYND Life Sciences Inc. |
Nicoll, Scott
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$18,000
+150,000 vol $0.12 each |
150,000 | |
| Filed 2022-08-10 13:26 Tx date 2022-08-09 |
$MYND
MYND Life Sciences Inc. |
Nicoll, Scott
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$18,000
+150,000 vol $0.12 each |
150,000 | |
| Filed 2022-08-10 13:26 Tx date 2022-08-09 |
$MYND
MYND Life Sciences Inc. |
Nicoll, Scott
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$18,000
+150,000 vol $0.12 each |
150,000 | |
| Filed 2022-08-10 13:21 Tx date 2021-10-27 |
$MYND
MYND Life Sciences Inc. |
Nicoll, Scott
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-08-10 13:21 Tx date 2021-10-27 |
$MYND
MYND Life Sciences Inc. |
Nicoll, Scott
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-08-10 13:21 Tx date 2021-10-27 |
$MYND
MYND Life Sciences Inc. |
Nicoll, Scott
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-08-10 13:21 Tx date 2021-10-27 |
$MYND
MYND Life Sciences Inc. |
Nicoll, Scott
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-08-10 11:52 Tx date 2022-08-09 |
$MYND
MYND Life Sciences Inc. |
Campbell, John
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$6,000
+50,000 vol $0.12 each |
200,000 | |
| Filed 2021-06-03 19:07 Tx date 2020-11-26 |
$MYND
MYND Life Sciences Inc. |
Bowden, Aaron
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
150,000 | ||
| Filed 2021-06-03 19:02 Tx date 2020-11-26 |
$MYND
MYND Life Sciences Inc. |
Ciullo, Paul
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
180,000 | ||
| Filed 2021-06-03 18:57 Tx date 2020-11-26 |
$MYND
MYND Life Sciences Inc. |
Jefferies, Wilfred
4 - Director of Issuer
Holder: 442668 BC Ltd. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
10,340,583 | ||
| Filed 2021-06-03 18:55 Tx date 2020-11-26 |
$MYND
MYND Life Sciences Inc. |
Jefferies, Wilfred
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
600,000 | ||
| Filed 2021-06-03 18:45 Tx date 2020-11-26 |
$MYND
MYND Life Sciences Inc. |
Ritchie-Derrien, Roslyn
4 - Director of Issuer
Holder: Copperstone Ventures Ltd. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,240,870 | ||
| Filed 2021-06-03 18:42 Tx date 2020-11-26 |
$MYND
MYND Life Sciences Inc. |
Ritchie-Derrien, Roslyn
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
150,000 | ||
| Filed 2021-06-03 18:28 Tx date 2020-11-26 |
$MYND
MYND Life Sciences Inc. |
Oberg, Lyle
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 1254791 BC Ltd. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,000,000 | ||
| Filed 2021-06-03 18:18 Tx date 2020-11-26 |
$MYND
MYND Life Sciences Inc. |
Oberg, Lyle
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,941,320 | ||
| Filed 2021-06-03 17:57 Tx date 2020-11-26 |
$MYND
MYND Life Sciences Inc. |
Oberg, Lyle
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
600,000 | ||
| Filed 2021-06-03 17:45 Tx date 2020-11-26 |
$MYND
MYND Life Sciences Inc. |
Campbell, John
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
50,000 | ||
| Filed 2021-06-03 17:41 Tx date 2020-11-26 |
$MYND
MYND Life Sciences Inc. |
Campbell, John
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
150,000 |